Skip to main content

Cardiovascular

Featured Article
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when…

Insights

“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients are…
When combining the high prevalence of hypertension with new aggressive treatment targets, a lot of patients may face the risk of having to take numerous drugs. In this week’s issue of Talking Therapeutics, Dr Jennings looks at a few recent and…

Interactive Features

In this episode of PopHealth Perspectives, Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga (dapagliflozin),…
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care…
According to study findings, older adults receiving statins after acute myocardial infarction experienced reduced 1-year mortality by what percent?
Among those who receive oral anticoagulation therapy, researchers were curious about the following question: “What are the longitudinal patterns of adherence to treatment with warfarin and direct oral anticoagulants among patients with atrial…
Back to Top